Clinical observation of a comorbid cardiac patient with a deficiency of VIII, IX blood clotting factors
- Authors: Tsygvintsev A.A.1, Gulyaev N.I.2, Lishchuk A.N.2, Shakhnovich P.G.3
-
Affiliations:
- Branch No. 4 of the A.A.Vishnevsky 3 Central Military Clinical Hospital of the Ministry of Defense of the Russian Federation
- The A.A. Vishnevsky 3rd Central Military Clinical Hospital of the Ministry of Defense of the Russian Federation
- Central Clinical Hospital with a polyclinic of the Administrative Department of the President of the Russian Federation
- Issue: Vol 343, No 5 (2022)
- Pages: 40-44
- Section: Treatment and prophylactic issues
- URL: https://journals.eco-vector.com/0026-9050/article/view/629650
- DOI: https://doi.org/10.52424/00269050_2022_343_5_40
- ID: 629650
Cite item
Open Access
Access granted
Subscription Access
Abstract
The treatment of comorbid patients with heart failure is traditionally associated with a high probability of polypharmacy and the realization of undesirable drug effects. The choice of management tactics for patients who have recently undergone cardiac surgery with a high risk of both thrombotic and hemorrhagic complications against the background of concomitant hematological pathology seems to be especially controversial. This paper presents the results of long-term clinical observation of a patient with a deficiency of VIII, IX factors of blood coagulation, cardiorenal anemic syndrome, performed by implantation of a pacemaker and stenting of the coronary artery. The tactics of managing such patients from the standpoint of evidence-based medicine are discussed.
About the authors
A. A. Tsygvintsev
Branch No. 4 of the A.A.Vishnevsky 3 Central Military Clinical Hospital of the Ministry of Defense of the Russian Federation
Author for correspondence.
Email: tsygvintsev1985@gmail.com
кандидат медицинских наук, капитан медицинской службы
Russian Federation, Krasnoznamensk, Moscow regionN. I. Gulyaev
The A.A. Vishnevsky 3rd Central Military Clinical Hospital of the Ministry of Defense of the Russian Federation
Email: tsygvintsev1985@gmail.com
доктор медицинских наук, полковник медицинской службы
Russian Federation, Krasnogorsk, Moscow RegionA. N. Lishchuk
The A.A. Vishnevsky 3rd Central Military Clinical Hospital of the Ministry of Defense of the Russian Federation
Email: tsygvintsev1985@gmail.com
заслуженный врач РФ, профессор, полковник медицинской службы запаса
Russian Federation, Krasnogorsk, Moscow RegionP. G. Shakhnovich
Central Clinical Hospital with a polyclinic of the Administrative Department of the President of the Russian Federation
Email: p_shakhnovich@mail.ru
доктор медицинских наук, полковник медицинской службы запаса
Russian Federation, MoscowReferences
- Ватутин Н.Т., Тарадин Г.Г., Канишева И.В., Венжега В.В. Анемия и железодефицит у больных с хронической сердечной недостаточностью // Кардиология. – 2019. – Т. 59, № 4. – С. 4–20.
- Галявич А.С., Стекольщикова Н.Ю., Касимова Р.А., Мухамедназарова Ф.И. Инфаркт миокарда и гемофилия // Рос. кардиол. журн. – 2016. – № 4. – С. 117–119.
- Мороз Е.В., Каратеев А.Е., Крюков Е.В., Чернецов В.А. Желудочно-кишечные кровотечения при использовании новых пероральных антикоагулянтов: эпидемиология, факторы риска, лечение и профилактика // Науч.-практ. ревматол. – 2017. – Т. 55, № 6. – С. 675–684.
- Anand I., Gupta P. Anemia and Iron Deficiency in Heart Failure: Current Concepts and Emerging Therapies // Circulation. – 2018. – Vol. 138, N 1. – P. 80–98.
- Bello N.A., Lewis E.F., Desai A.S et al. Increased risk of stroke with darbepoetin alfa in anaemic heart failure patients with diabetes and chronic kidney disease // Eur. J. Heart Fail. – 2015. – Vol. 17, N 11. – P. 1201–1207.
- Grote Beverborg N., van Veldhuisen D.J., van der Meer P. Anemia in Heart Failure // JACC: Heart Failure. – 2018. – Vol. 6, N 3. – P. 201–208.
- Van der Wal H., Comin-Colet J., Klip I. et al. Vitamin B12 and folate deficiency in chronic heart failure // Heart. – 2015. – Vol. 101, N 4. – P. 302–310.
Supplementary files
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).